Alliance Imaging of Orange, CA, reported last week that it has completed the final phase of its refinancing effort after GE Medical Systems of Milwaukee converted an $18 million bridge loan into preferred stock, giving GEMS a 21% stake in the mobile
Alliance Imaging of Orange, CA, reported last week that it has completed the final phase of its refinancing effort after GE Medical Systems of Milwaukee converted an $18 million bridge loan into preferred stock, giving GEMS a 21% stake in the mobile imaging provider. Alliance said that the conversion puts the company into a stronger financial position to make acquisitions and investments in new imaging systems.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.